ADIENNE Pharma and Biotech

ADIENNE Pharma & Biotech (ADIENNE) is a bio-pharmaceutical company which is into wide number of fields. The company is into research and development in the fields of Rare diseases, Onco-Haematology, Bone Marrow Transplantation, Solid Organ Transplantation, Autoimmune diseases, Toxicology, and Neurology. It is also into cell therapy and gene therapy. ADIENNE is primarily engaged in fulfilling the unmet market needs in the field of onco-haematology and rare diseases. Recently, the company received the orphan drug designation for its recombinant human minibody SAND5 RGD by the FDA. ADIENNE is headquartered in Bergamo, Italy.

Street: 
Via Broseta, 64/B
City: 
Bergamo
Postcode: 
24128
Federal State : 
Italy
WebSite: 
www.adienne.com
Fax: 
39-35-258672

Company Index Score

Current Index Score Historical Index Score
  • ADIENNE Pharma and Biotech currently scores 50 % in the index.
  • ADIENNE Pharma and Biotech is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • ADIENNE Pharma and Biotech is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets